SCIENTIFIC, CLINICAL AND COMMERCIAL DEVELOPMENT OF RNA THERAPEUTICS AND VACCINES
Discover, develop & get to market by assessing the latest data and business strategies from global RNA experts across the entire RNA ecosystem - mRNA vaccines & therapeutics, short & non-coding RNAs, non-linear RNA, gene editing, delivery solutions & RNA as a target.
September 4-5, 2024
San Diego Convention Center, USA
|Antisense Technologies||Circular RNA|
|CRISPR, RNA & Gene Editing||Gene Therapy Approaches|
|mRNA Therapeutics||mRNA Vaccines|
|Nucleic Acid Therapeutics||RNA Activation|
|RNA Cell Therapy||RNA Delivery|
|RNA Diagnostics||RNA Epigenetics|
|RNA Interference||Self-amplifying RNA|
|Small Molecules Targeting RNA||tRNA|
Why RNA Leaders?
Join the leading RNA dedicated forum delivering access to business partnering opportunities with your C-level biotech, pharmaceutical heads and industry peers.
And in the words of Moderna’s CSO, Melissa Moore, “when I saw some other speakers who had been invited, I felt this would be a really great place to connect with and network with my peers”.
Meet 2023 speakers - BioNTech, Ionis, J&J & more!
VP, Global Head of RNA, Gene Therapy & Delivery, Janssen
SVP RNA Biochemistry & Manufacturing, BioNTech SE
EVP, CBO, Gritstone
Head of Advanced Drug Delivery, AstraZeneca
EVP of Research, Ionis
VP Delivery Platform, Beam Therapeutics
AVP, Genetic Medicine, Eli Lilly
CEO, Orna Therapeutics
CBO, Anima Biotech
Head of Strategic Partnership & Innovation, mRNA, Sanofi
CMC Lead, CEPI
CSTO, Avidity Biosciences
Partner, UCB Ventures
CEO, Tessera Therapeutics
Partner, MRL Ventures Fund
VP for Clinical Development, BioNTech
Key areas of focus
mRNA Vaccines & Therapeutics
Delve into process development mRNA therapeutics and saRNA approaches. Including:
Explore movement to clinic of ASOs, siRNA and short RNAs. Including:
Next Generation RNA
Venture into emerging applications of RNA 2.0 such circRNA, lncRNAs, RNA editing, delivery tools and RNA as target. Including:
Great insights about technological innovations that pharma/investors would like to see in the coming years.
LSX are particularly good at bringing together a high quality network and facilitating new connections to allow best practice to be shared.
RNA leaders congress brought startups and established pharmaceutical companies in a single platform. Helps to share the value and views of experts in the field and expands the network.